Mechanisms of inactivation of E-cadherin in breast cancer cell lines - PubMed (original) (raw)
. 1998 May 1;58(9):1972-7.
T Godfrey, H Nakamura, J Graff, C Collins, L Shayesteh, N Doggett, K Johnson, M Wheelock, J Herman, S Baylin, D Pinkel, J Gray
Affiliations
- PMID: 9581841
Mechanisms of inactivation of E-cadherin in breast cancer cell lines
S Hiraguri et al. Cancer Res. 1998.
Abstract
Loss of E-cadherin (CDH1) function is thought to contribute to progression in breast cancer and other solid tumors by increasing proliferation, invasion, and/or metastasis. In some cases, the restoration of CDH1 function may be an important therapeutic option. This possibility will depend on the mechanism by which CDH1 is inactivated. Here we present analyses of CDH1 expression, genetic mutation, and promoter methylation in CDH1 in 10 commonly used breast cancer cell lines. Five cell lines (BT-474, MCF-7, MDA-MB-361, MDA-MB-468, and T-47D) expressed CDH1 and were genetically normal. Five others (SK-BR-3, 600 MPE, MDA-MB-134 IV, CAMA1, and MDA-MB-435) did not express CDH1. Fluorescence in situ hybridization analyses of each of these cell lines showed evidence for the physical deletion of one allele of CDH1, and three cell lines were found to carry homozygous deletions. SK-BR-3 was deleted from exon 12 through the promoter; exon 6 was deleted in MDA-MB-134 IV cells, and 600 MPE cells carried a 21-bp deletion in the splicing acceptor site for exon 9. CAMA1 seemed to have been inactivated through promoter methylation. No explanation was found for the inactivation of CDH1 in MDA-MB-435.
Similar articles
- Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. Toyooka KO, et al. Cancer Res. 2001 Jun 1;61(11):4556-60. Cancer Res. 2001. PMID: 11389090 - Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.
Lombaerts M, Middeldorp JW, van der Weide E, Philippo K, van Wezel T, Smit VT, Cornelisse CJ, Cleton-Jansen AM. Lombaerts M, et al. Biochem Biophys Res Commun. 2004 Jun 25;319(2):697-704. doi: 10.1016/j.bbrc.2004.05.041. Biochem Biophys Res Commun. 2004. PMID: 15178462 - CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR. Caldeira JR, et al. BMC Cancer. 2006 Mar 2;6:48. doi: 10.1186/1471-2407-6-48. BMC Cancer. 2006. PMID: 16512896 Free PMC article. - Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
Chen S, Ye J, Kijima I, Kinoshita Y, Zhou D. Chen S, et al. J Steroid Biochem Mol Biol. 2005 May;95(1-5):17-23. doi: 10.1016/j.jsbmb.2005.04.002. J Steroid Biochem Mol Biol. 2005. PMID: 15955695 Review. - E-cadherin deregulation in breast cancer.
Corso G, Figueiredo J, De Angelis SP, Corso F, Girardi A, Pereira J, Seruca R, Bonanni B, Carneiro P, Pravettoni G, Guerini Rocco E, Veronesi P, Montagna G, Sacchini V, Gandini S. Corso G, et al. J Cell Mol Med. 2020 Jun;24(11):5930-5936. doi: 10.1111/jcmm.15140. Epub 2020 Apr 16. J Cell Mol Med. 2020. PMID: 32301282 Free PMC article. Review.
Cited by
- Endolysosomal TRPML1 channel regulates cancer cell migration by altering intracellular trafficking of E-cadherin and β1-integrin.
Frey N, Ouologuem L, Blenninger J, Siow WX, Thorn-Seshold J, Stöckl J, Abrahamian C, Fröhlich T, Vollmar AM, Grimm C, Bartel K. Frey N, et al. J Biol Chem. 2024 Jan;300(1):105581. doi: 10.1016/j.jbc.2023.105581. Epub 2023 Dec 21. J Biol Chem. 2024. PMID: 38141765 Free PMC article. - Genes, chromatin, and breast cancer: an epigenetic tale.
Mielnicki LM, Asch HL, Asch BB. Mielnicki LM, et al. J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):169-82. doi: 10.1023/a:1011356623442. J Mammary Gland Biol Neoplasia. 2001. PMID: 11501577 Review. - E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.
Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, Cleton-Jansen AM. Lombaerts M, et al. Br J Cancer. 2006 Mar 13;94(5):661-71. doi: 10.1038/sj.bjc.6602996. Br J Cancer. 2006. PMID: 16495925 Free PMC article. - Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer.
Protheroe AS, Banks RE, Mzimba M, Porter WH, Southgate J, Singh PN, Bosomworth M, Harnden P, Smith PH, Whelan P, Selby PJ. Protheroe AS, et al. Br J Cancer. 1999 Apr;80(1-2):273-8. doi: 10.1038/sj.bjc.6690351. Br J Cancer. 1999. PMID: 10390008 Free PMC article. - E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus.
Wijnhoven BP, de Both NJ, van Dekken H, Tilanus HW, Dinjens WN. Wijnhoven BP, et al. Br J Cancer. 1999 Jul;80(10):1652-7. doi: 10.1038/sj.bjc.6690577. Br J Cancer. 1999. PMID: 10408414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous